Stock listing
NASDAQ:AKBA Akebia Therapeutics, Inc. Stock
Home listing (NASDAQ) of Akebia Therapeutics, Inc.
Follow Akebia Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:AKBA
$0.707 USD -0.036 (-4.8%)
Close on Oct 30, 2026
- Day range
- $0.695 – $0.735 USDOct 30, 2026
- Volume
- 2.77M sharesOct 30, 2026
- Market cap
- $195.8M USDAt the close on Oct 30, 2026 · price × 277.1M shares outstanding
- 52-week range
- $0.542 – $2.230 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $6.58M USDMedian day 7.25M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:AKBA · Home | $0.707 USD | -0.036 (-4.8%) | 2,771,081 | $0.721 | $0.735 | $0.695 | $0.742 | Close on Oct 30, 2026 |
| Frankfurt:AX9 | €0.507 EUR | +0.012 (+2.5%) | — | €0.507 | €0.507 | €0.507 | €0.494 | Close on Oct 26, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:AKBA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.707 | -0.036 | -4.8% | $0.721 | $0.735 | $0.695 | 2,771,081 | |
| $0.742 | -0.022 | -2.9% | $0.780 | $0.800 | $0.737 | 5,018,626 | |
| $0.765 | +0.104 | +15.8% | $0.666 | $0.777 | $0.657 | 6,940,322 | |
| $0.660 | +0.017 | +2.6% | $0.637 | $0.680 | $0.637 | 5,384,290 | |
| $0.644 | +0.077 | +13.6% | $0.594 | $0.675 | $0.577 | 11,519,901 | |
| $0.567 | +0.005 | +0.8% | $0.566 | $0.596 | $0.562 | 10,991,053 | |
| $0.562 | -0.023 | -3.9% | $0.575 | $0.604 | $0.542 | 13,099,216 | |
| $0.585 | -0.033 | -5.3% | $0.609 | $0.640 | $0.571 | 19,365,372 | |
| $0.618 | -0.062 | -9.1% | $0.680 | $0.706 | $0.612 | 9,961,412 | |
| $0.680 | +0.010 | +1.5% | $0.674 | $0.700 | $0.670 | 7,755,510 | |
| $0.670 | -0.025 | -3.7% | $0.703 | $0.734 | $0.666 | 7,127,831 | |
| $0.696 | -0.006 | -0.9% | $0.704 | $0.725 | $0.690 | 8,917,530 | |
| $0.702 | -0.068 | -8.8% | $0.750 | $0.770 | $0.700 | 13,956,352 | |
| $0.770 | -0.020 | -2.5% | $0.800 | $0.805 | $0.766 | 6,497,900 | |
| $0.790 | -0.011 | -1.4% | $0.800 | $0.807 | $0.772 | 8,869,300 | |
| $0.801 | -0.014 | -1.7% | $0.820 | $0.832 | $0.801 | 6,090,600 | |
| $0.815 | -0.058 | -6.6% | $0.852 | $0.866 | $0.815 | 7,445,500 | |
| $0.873 | -0.006 | -0.7% | $0.863 | $0.887 | $0.863 | 9,163,300 | |
| $0.879 | -0.032 | -3.5% | $0.902 | $0.909 | $0.875 | 6,178,400 | |
| $0.911 | +0.046 | +5.3% | $0.870 | $0.920 | $0.845 | 7,505,000 | |
| $0.865 | -0.006 | -0.7% | $0.888 | $0.889 | $0.840 | 7,105,000 | |
| $0.871 | -0.049 | -5.3% | $0.915 | $0.920 | $0.868 | 4,514,800 | |
| $0.920 | +0.034 | +3.8% | $0.894 | $0.931 | $0.866 | 10,827,300 | |
| $0.886 | -0.007 | -0.8% | $0.900 | $0.900 | $0.870 | 3,448,900 | |
| $0.893 | -0.003 | -0.3% | $0.886 | $0.900 | $0.875 | 3,399,300 | |
| $0.896 | -0.023 | -2.5% | $0.921 | $0.927 | $0.893 | 4,374,700 | |
| $0.919 | -0.014 | -1.5% | $0.920 | $0.948 | $0.910 | 3,729,900 | |
| $0.933 | -0.047 | -4.8% | $0.987 | $0.987 | $0.930 | 5,391,000 | |
| $0.980 | +0.041 | +4.4% | $0.950 | $1.000 | $0.940 | 5,111,300 | |
| $0.939 | +0.023 | +2.5% | $0.927 | $0.946 | $0.918 | 11,093,400 | |
| $0.916 | +0.020 | +2.2% | $0.890 | $0.927 | $0.880 | 7,372,100 | |
| $0.896 | -0.022 | -2.4% | $0.926 | $0.940 | $0.870 | 8,717,300 | |
| $0.918 | +0.015 | +1.7% | $0.908 | $0.936 | $0.895 | 7,502,700 | |
| $0.903 | -0.060 | -6.2% | $0.962 | $0.977 | $0.903 | 5,772,400 | |
| $0.963 | +0.011 | +1.2% | $0.952 | $1.020 | $0.903 | 8,832,900 | |
| $0.952 | +0.005 | +0.5% | $0.970 | $0.983 | $0.951 | 6,140,400 | |
| $0.947 | -0.007 | -0.7% | $0.950 | $0.968 | $0.931 | 4,921,000 | |
| $0.954 | -0.076 | -7.4% | $1.030 | $1.049 | $0.950 | 4,872,800 | |
| $1.030 | +0.055 | +5.6% | $0.962 | $1.030 | $0.953 | 3,058,700 | |
| $0.975 | -0.008 | -0.8% | $0.988 | $0.996 | $0.947 | 8,347,900 | |
| $0.983 | +0.003 | +0.3% | $1.000 | $1.000 | $0.962 | 7,456,600 | |
| $0.980 | +0.035 | +3.7% | $0.950 | $1.010 | $0.947 | 12,854,800 | |
| $0.945 | +0.026 | +2.8% | $0.910 | $0.947 | $0.910 | 12,453,200 | |
| $0.919 | +0.040 | +4.6% | $0.880 | $0.935 | $0.855 | 15,180,000 | |
| $0.879 | -0.061 | -6.5% | $0.935 | $0.940 | $0.865 | 10,188,400 | |
| $0.940 | +0.033 | +3.6% | $0.910 | $0.960 | $0.906 | 13,287,300 | |
| $0.907 | -0.051 | -5.3% | $0.957 | $0.957 | $0.876 | 14,028,700 | |
| $0.958 | +0.057 | +6.3% | $0.900 | $0.963 | $0.900 | 11,341,000 | |
| $0.901 | -0.006 | -0.7% | $0.908 | $0.911 | $0.872 | 8,125,100 | |
| $0.907 | -0.012 | -1.3% | $0.925 | $0.955 | $0.905 | 6,450,100 | |
| $0.919 | +0.034 | +3.8% | $0.880 | $0.930 | $0.872 | 13,718,500 | |
| $0.885 | +0.033 | +3.9% | $0.852 | $0.898 | $0.850 | 9,875,800 | |
| $0.852 | -0.008 | -0.9% | $0.857 | $0.863 | $0.838 | 1,955,500 | |
| $0.860 | -0.013 | -1.5% | $0.870 | $0.880 | $0.814 | 4,263,900 | |
| $0.873 | +0.003 | +0.3% | $0.870 | $0.888 | $0.858 | 2,087,500 | |
| $0.870 | -0.023 | -2.6% | $0.905 | $0.949 | $0.864 | 4,092,700 | |
| $0.893 | +0.026 | +3.0% | $0.872 | $0.910 | $0.867 | 4,555,000 | |
| $0.867 | +0.023 | +2.7% | $0.840 | $0.885 | $0.840 | 3,793,800 | |
| $0.844 | -0.066 | -7.3% | $0.900 | $0.909 | $0.837 | 8,489,800 | |
| $0.910 | -0.044 | -4.6% | $0.961 | $0.962 | $0.886 | 10,934,400 | |
| $0.954 | -0.336 | -26.0% | $0.902 | $1.010 | $0.850 | 17,685,500 | |
| $1.290 | -0.030 | -2.3% | $1.320 | $1.355 | $1.280 | 4,527,700 | |
| $1.320 | +0.010 | +0.8% | $1.310 | $1.350 | $1.310 | 2,695,500 | |
| $1.310 | -0.010 | -0.8% | $1.310 | $1.340 | $1.295 | 2,095,900 | |
| $1.320 | -0.030 | -2.2% | $1.340 | $1.349 | $1.295 | 2,057,600 | |
| $1.350 | +0.090 | +7.1% | $1.240 | $1.360 | $1.240 | 3,117,100 |
- Ticker
- NASDAQ:AKBA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights
Latest earnings call · Aug 5, 2026
Akebia Therapeutics (NASDAQ:AKBA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Apr 2, 2026
Investor Day (April 2026)
Investor day · 55 slides
Calls
Upcoming
Akebia Therapeutics (NASDAQ:AKBA) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 8:00 AM ET
Register
Replays
Akebia Therapeutics (NASDAQ:AKBA) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptAkebia Therapeutics (NASDAQ:AKBA) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:00 AM ET
Watch TranscriptAkebia Therapeutics (NASDAQ:AKBA) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights
Oct 29, 2026
Closed $0.742 (-2.9%) on Oct 29, 2026
U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week
Oct 26, 2026
Closed $0.644 (+13.6%) on Oct 26, 2026
Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
Oct 7, 2026
Closed $0.873 (-0.7%) on Oct 7, 2026
Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia’s Rare Kidney Pipeline at ASN Kidney Week 2026
Oct 6, 2026
Closed $0.879 (-3.5%) on Oct 6, 2026
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 1, 2026
Closed $0.865 (-0.7%) on Oct 2, 2026
Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases
Sep 14, 2026
Closed $0.963 (+1.2%) on Sep 14, 2026
Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston
Sep 1, 2026
Closed $0.945 (+2.8%) on Sep 1, 2026
Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Aug 5, 2026
Closed $0.954 (-26.0%) on Aug 6, 2026
Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases
Aug 3, 2026
Closed $1.31 (-0.8%) on Aug 3, 2026
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
Jul 29, 2026
Closed $1.26 (-0.8%) on Jul 29, 2026
Decks
Investor Day (April 2026)
Investor day · 55 slides · Apr 2, 2026
Q4 2025 Earnings Presentation
Earnings · 25 slides · Feb 26, 2026
Investor Presentation (January 2026)
Investor deck · 25 slides · Jan 12, 2026
Q2 2025 Earnings Presentation
Earnings · 25 slides · Aug 7, 2025
Akebia Therapeutics, Inc. on 6ix
- News releases
- 31 in the last 12 months · 183 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 21 calls with a replay · 21 with a transcript · latest Aug 5, 2026
- Decks
- 18 decks · latest Apr 2, 2026
Where Akebia Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AKBA · Home listing · This page | NASDAQ | United States | USD |
| Tradegate:AX9 | Tradegate | Germany | EUR |
| LS Exchange:A1XF0S | LS Exchange | Germany | EUR |
| BOATS:AKBA | BOATS | United States | USD |
| Lang & Schwarz:A1XF0S | Lang & Schwarz | Germany | EUR |
| gettex:AX9 | gettex | Germany | EUR |
| Hamburg:AX9 | Hamburg | Germany | EUR |
| BX Swiss:AX9 | BX Swiss | Switzerland | CHF |
| Dusseldorf:AX9 | Dusseldorf | Germany | EUR |
| Frankfurt:AX9 | Frankfurt | Germany | EUR |
| Munich:AX9 | Munich | Germany | EUR |
| Stuttgart:AX9 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Akebia Therapeutics, Inc.